As of 2024-12-15, the Relative Valuation of Ikena Oncology Inc (IKNA) is 1.64 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.65 USD, the upside of Ikena Oncology Inc based on Relative Valuation is -0.8%.
The range of the Relative Valuation is 1.64 - 1.64 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -1.5x - -1.5x | -1.5x |
| Fair Price | 1.64 - 1.64 | 1.64 |
| Upside | -0.8% - -0.8% | -0.8% |
| Date | P/E |
| 2024-12-12 | -1.53 |
| 2024-12-11 | -1.56 |
| 2024-12-10 | -1.56 |
| 2024-12-09 | -1.53 |
| 2024-12-06 | -1.54 |
| 2024-12-05 | -1.54 |
| 2024-12-04 | -1.56 |
| 2024-12-03 | -1.56 |
| 2024-12-02 | -1.57 |
| 2024-11-29 | -1.59 |
| 2024-11-27 | -1.55 |
| 2024-11-26 | -1.57 |
| 2024-11-25 | -1.57 |
| 2024-11-22 | -1.57 |
| 2024-11-21 | -1.59 |
| 2024-11-20 | -1.56 |
| 2024-11-19 | -1.54 |
| 2024-11-18 | -1.54 |
| 2024-11-15 | -1.55 |
| 2024-11-14 | -1.57 |
| 2024-11-13 | -1.59 |
| 2024-11-12 | -1.61 |
| 2024-11-11 | -1.60 |
| 2024-11-08 | -1.61 |
| 2024-11-07 | -1.55 |
| 2024-11-06 | -1.58 |
| 2024-11-05 | -1.55 |
| 2024-11-04 | -1.58 |
| 2024-11-01 | -1.58 |
| 2024-10-31 | -1.57 |
| 2024-10-30 | -1.56 |
| 2024-10-29 | -1.57 |
| 2024-10-28 | -1.58 |
| 2024-10-25 | -1.58 |
| 2024-10-24 | -1.57 |
| 2024-10-23 | -1.55 |
| 2024-10-22 | -1.55 |
| 2024-10-21 | -1.55 |
| 2024-10-18 | -1.57 |
| 2024-10-17 | -1.57 |
| 2024-10-16 | -1.58 |
| 2024-10-15 | -1.57 |
| 2024-10-14 | -1.58 |
| 2024-10-11 | -1.58 |
| 2024-10-10 | -1.58 |
| 2024-10-09 | -1.57 |
| 2024-10-08 | -1.56 |
| 2024-10-07 | -1.55 |
| 2024-10-04 | -1.56 |
| 2024-10-03 | -1.53 |